|
|
|
Volumn 3, Issue 6, 2004, Pages 490-
|
|
Early success of combined EGFR and Her2 receptor blockade as a clinical strategy in breast cancer
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
EPIDERMAL GROWTH FACTOR RECEPTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
LAPATINIB;
TRASTUZUMAB;
ANEMIA;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CLINICAL TRIAL;
DIARRHEA;
DRUG EFFECT;
DRUG SAFETY;
FATIGUE;
HEART INJURY;
HUMAN;
LIVER INJURY;
NAUSEA;
NOTE;
RASH;
RECEPTOR BLOCKING;
|
|
EID: 25144497069
PISSN: 15384047
EISSN: 15558576
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|
